RxDoctor Payments Data

Melissa Murray, MD

Family Medicine · Saint Louis, MONPI 1689651168

Payments from drug & device makers

$15,281in general payments, 2019–2025

Across 957 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • AstraZeneca$1K
  • Lilly USA, LLC$984
  • Pfizer$926
  • Novo Nordisk$923
  • GSK$834
  • plus $6K from 47 others

What the payments were for

  • Food & beverage$15,272100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$15,281 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$85,829
Medicare patients
130
Services billed
3,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide138$129,555
EliquisApixaban123$113,170
Teriparatide32$97,390
MounjaroTirzepatide69$75,203
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$52,438
FarxigaDapagliflozin Propanediol73$51,039
Semglee (Yfgn) PenInsulin Glargine-Yfgn50$32,567
TrintellixVortioxetine Hydrobromide34$27,491
VraylarCariprazine Hcl17$24,539
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$19,297
Soliqua 100-33Insulin Glargine/Lixisenatide20$17,940
JanuviaSitagliptin Phosphate15$15,504
AuvelityDextromethorphan Hbr/Bupropion13$14,190
TrulicityDulaglutide14$14,175
ArexvyRsvpref3 Antigen/As01e/Pf48$13,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$923$129,555138 claims
PfizerEliquis, Nurtec Odt$926$125,494135 claims
Lilly USA, LLCMounjaro, Trulicity$984$89,37883 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Incruse Ellipta$834$79,786153 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,104$64,998101 claims
AbbVieVraylar, Synthroid$4,276$31,70991 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$504$27,49134 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$131$17,94020 claims
Boehringer IngelheimCombivent Respimat, Jardiance$255$16,12228 claims
MerckJanuvia$149$15,50415 claims
Axsome Therapeutics, Inc.Auvelity$215$14,19013 claims
Johnson & JohnsonXarelto$381$11,43316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →